Avastin dilemma accusing normal ophthalmologists for criminals

‘Avastin(generic name: bevacizumab),’ which has been widely used without approval as the age-related macular degeneration treatment, has been in a dilemma.

Recently, an ophthalmologist who injected Avastin to treat macular degeneration was close to be accused by a private insurance company and returned medical fees to the patient.

“We need to stop accusing ophthalmologists trying hard to prev...